Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities

Combination of CDK4/6 inhibitors and endocrine therapy improves clinical outcome in advanced oestrogen receptor (ER)-positive breast cancer, however relapse is inevitable. Here, we show in model systems that other than loss of RB1 few gene-copy number (CN) alterations are associated with irreversibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pancholi, Sunil, Ribas, Ricardo, Simigdala, Nikiana, Schuster, Eugene, Nikitorowicz-Buniak, Joanna, Ressa, Anna, Gao, Qiong, Leal, Mariana Ferreira, Bhamra, Amandeep, Thornhill, Allan, Morisset, Ludivine, Montaudon, Elodie, Sourd, Laura, Fitzpatrick, Martin, Altelaar, Maarten, Johnston, Stephen R., Marangoni, Elisabetta, Dowsett, Mitch, Martin, Lesley-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299844/
https://www.ncbi.nlm.nih.gov/pubmed/32307447
http://dx.doi.org/10.1038/s41388-020-1284-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299844/
https://www.ncbi.nlm.nih.gov/pubmed/32307447
http://dx.doi.org/10.1038/s41388-020-1284-6

Ejemplares similares